Latest Insider Transactions at Nuance Communications, Inc. (NUAN)
This section provides a real-time view of insider transactions for Nuance Communications, Inc. (NUAN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nuance Communications, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nuance Communications, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 03
2021
|
Robert Weideman EVP & GM, Enterprise Division |
SELL
Payment of exercise price or tax liability
|
Direct |
3,653
-1.57%
|
$200,915
$55.2 P/Share
|
|
Sep 14
2021
|
Lloyd Carney Director |
SELL
Open market or private sale
|
Direct |
11,820
-20.83%
|
$650,100
$55.22 P/Share
|
|
Sep 10
2021
|
Daniel David Tempesta EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,300
-4.68%
|
$676,500
$55.19 P/Share
|
|
Aug 24
2021
|
Robert Weideman EVP & GM, Enterprise Division |
SELL
Open market or private sale
|
Direct |
215,838
-48.16%
|
$11,871,090
$55.06 P/Share
|
|
Jul 15
2021
|
Sanjay Vaswani Director |
SELL
Bona fide gift
|
Direct |
14,050
-19.15%
|
$758,700
$54.86 P/Share
|
|
Jun 08
2021
|
Lloyd Carney Director |
SELL
Open market or private sale
|
Direct |
36,002
-67.3%
|
$1,944,108
$54.98 P/Share
|
|
Jun 07
2021
|
Robert Weideman EVP & GM, Enterprise Division |
SELL
Open market or private sale
|
Direct |
11,182
-2.44%
|
$615,010
$55.0 P/Share
|
|
Jun 02
2021
|
Diana L Nole EVP & GM, Healthcare Division |
SELL
Open market or private sale
|
Direct |
20,978
-19.24%
|
$1,111,834
$53.21 P/Share
|
|
Jun 01
2021
|
Diana L Nole EVP & GM, Healthcare Division |
SELL
Payment of exercise price or tax liability
|
Direct |
18,455
-7.49%
|
$978,115
$53.09 P/Share
|
|
May 17
2021
|
Mark D Benjamin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,828
-2.52%
|
$1,083,056
$52.55 P/Share
|
|
May 14
2021
|
Joseph Carl Petro EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
50,822
-26.3%
|
$2,642,744
$52.78 P/Share
|
|
May 14
2021
|
Mark D Benjamin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
169,400
-17.02%
|
$8,808,800
$52.59 P/Share
|
|
Apr 29
2021
|
Robert Dahdah EVP & Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
44,118
-8.33%
|
$2,338,254
$53.21 P/Share
|
|
Apr 23
2021
|
Mark D Benjamin Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
393,472
-11.53%
|
$20,854,016
$53.09 P/Share
|
|
Apr 23
2021
|
Mark D Benjamin Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
765,932
+36.51%
|
-
|
|
Apr 12
2021
|
Daniel David Tempesta EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
120,342
-3.93%
|
$6,257,784
$52.93 P/Share
|
|
Apr 01
2021
|
Daniel David Tempesta EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
21,000
-1.3%
|
$945,000
$45.01 P/Share
|
|
Mar 01
2021
|
Daniel David Tempesta EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
21,000
-1.67%
|
$945,000
$45.27 P/Share
|
|
Jan 01
2021
|
Daniel J. Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,670
+9.58%
|
-
|
|
Jan 01
2021
|
Lloyd Carney Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,670
+9.58%
|
-
|
|
Jan 01
2021
|
Robert J Finocchio Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,670
+4.29%
|
-
|
|
Jan 01
2021
|
Mark R Laret Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,670
+6.53%
|
-
|
|
Jan 01
2021
|
Sanjay Vaswani Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,670
+7.17%
|
-
|
|
Jan 01
2021
|
Thomas D Ebling Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,670
+9.58%
|
-
|
|
Jan 01
2021
|
Michal Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,670
+9.58%
|
-
|
|
Dec 08
2020
|
Diana L Nole EVP & GM, Healthcare Division |
SELL
Open market or private sale
|
Direct |
1,836
-1.42%
|
$77,112
$42.04 P/Share
|
|
Dec 04
2020
|
Mark D Benjamin Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,876
-2.03%
|
$540,792
$42.06 P/Share
|
|
Dec 04
2020
|
Wendy Cassity EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,621
-4.37%
|
$152,082
$42.06 P/Share
|
|
Dec 04
2020
|
Daniel David Tempesta EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,023
-0.94%
|
$168,966
$42.06 P/Share
|
|
Dec 04
2020
|
Robert Weideman EVP & GM, Enterprise Division |
SELL
Payment of exercise price or tax liability
|
Direct |
4,023
-0.87%
|
$168,966
$42.06 P/Share
|
|
Dec 04
2020
|
Arthur G. Giterman Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,877
-2.02%
|
$78,834
$42.06 P/Share
|
|
Dec 04
2020
|
Joseph Carl Petro EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,023
-2.04%
|
$168,966
$42.06 P/Share
|
|
Dec 04
2020
|
Diana L Nole EVP & GM, Healthcare Division |
SELL
Payment of exercise price or tax liability
|
Direct |
1,171
-0.9%
|
$49,182
$42.06 P/Share
|
|
Dec 04
2020
|
Robert Dahdah EVP & Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,023
-1.47%
|
$168,966
$42.06 P/Share
|
|
Nov 25
2020
|
Robert Dahdah EVP & Chief Revenue Officer |
SELL
Bona fide gift
|
Direct |
620
-0.23%
|
$26,040
$42.87 P/Share
|
|
Nov 25
2020
|
Joseph Carl Petro EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
59,523
-23.18%
|
$2,499,966
$42.01 P/Share
|
|
Nov 24
2020
|
Arthur G. Giterman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,489
-1.58%
|
$62,538
$42.5 P/Share
|
|
Nov 24
2020
|
Mark D Benjamin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
117,946
-15.65%
|
$4,835,786
$41.67 P/Share
|
|
Nov 23
2020
|
Robert Dahdah EVP & Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
12,000
-4.19%
|
$504,000
$42.09 P/Share
|
|
Nov 23
2020
|
Arthur G. Giterman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,042
-3.12%
|
$127,764
$42.45 P/Share
|
|
Nov 23
2020
|
Daniel David Tempesta EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
102,833
-19.35%
|
$4,216,153
$41.66 P/Share
|
|
Nov 20
2020
|
Wendy Cassity EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
25,725
-12.36%
|
$1,003,275
$39.3 P/Share
|
|
Nov 20
2020
|
Wendy Cassity EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,165
+7.0%
|
-
|
|
Nov 20
2020
|
Arthur G. Giterman Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,234
+4.16%
|
-
|
|
Nov 20
2020
|
Diana L Nole EVP & GM, Healthcare Division |
BUY
Grant, award, or other acquisition
|
Direct |
3,007
+2.25%
|
-
|
|
Nov 20
2020
|
Joseph Carl Petro EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,073
+3.41%
|
-
|
|
Nov 20
2020
|
Daniel David Tempesta EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,073
+1.68%
|
-
|
|
Nov 20
2020
|
Robert Weideman EVP & GM, Enterprise Division |
BUY
Grant, award, or other acquisition
|
Direct |
9,073
+1.92%
|
-
|
|
Nov 20
2020
|
Mark D Benjamin Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,034
+3.71%
|
-
|
|
Nov 20
2020
|
Robert Dahdah EVP & Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,073
+3.07%
|
-
|